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Abstract 
This article critically analyses the concept of evidence in evidence-based-policy, arguing that 
there is key problem: that there is no existing practicable theory of evidence, one which is 
philosophically grounded and yet applicable for evidence-based policy. The article critically 
considers both philosophical accounts of evidence and practical treatments of evidence in 
evidence-based-policy. It argues that both fail in different ways to provide a theory of 
evidence that is adequate for evidence-based-policy. The article contributes to the debate 
about how evidence can and should be used to reduce contingency in science and in policy 
based on science. 
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The rise of evidence-based policy 
In both the UK and the US there is an increasing drive to use evidence to inform, develop 
and refine policy and practice. This push to improve how research and analysis informs 
policy and practice is increasingly being felt in a wide range of areas: in addition to evidence-
based health and social care, we now hear of evidence-based housing policy, transport 
policy, education and criminal justice. Since the election of the Labour Government in 1997, 
the UK has been firmly committed to evidence-based policy as a way of developing social 
programmes. The UK Government signalled its commitment to evidence-based policy in the 
1999 White Paper Modernising Government, which calls for the ‘better use of evidence and 
research in policy-making and better focus on policies that will deliver long term goals’ and 
stipulates evidence as a key principle for policy making (Cabinet Office, 1999: 16). A year 
later, the Cabinet Office’s Performance and Innovation Unit (2000) called for a ‘fundamental 
change in culture’ in order to place good analysis at the centre of policy-making and 
recommended that training for new Ministers and senior civil servants ‘should emphasise the 
importance of analysis for evidence-based policy’ (p4). In response to this recommendation 
the UK’s National School of Government, which provides training for the civil service, now 
runs regular courses on analytical skills and evaluation methods, including introductions to, 
and overviews of, evidence-based policy making.  
 
An example of evidence-based approach to policy making is the UK Sure Start programme. 
Initiated in 2001, the aim of the programme is to break the cycle of poverty by providing 
children and families with childcare, health and educational support. The Sure Start 
programme has been evidence-based from the start, using extensive reviews of research 
findings on what approaches and early interventions are most likely to work; its execution 
and continuing evaluation and refinement have also been evidence-based (Hunter, 2003). 
Another notable example is the UK’s National Institute for Clinical Excellence (NICE)i, which 
provides regulatory guidelines for the National Health Service (NHS) on particular 
treatments. These guidelines are based on reviews on the effectiveness and cost-
effectiveness of various treatments.  
 
In the US, the Department of Education is actively committed to furthering evidence-based 
approaches to education policy and practice. The Department’s Institute of Education 
Sciences established the What Works Clearinghouse in 2002 ‘to provide educators, 
policymakers, researchers, and the public with a central and trusted source of scientific 
evidence of what works in education’ii. Furthermore, the Department in 2005 implemented a 
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recommendation by the Coalition for Evidence-Based Policyiii that projects that include a 
randomised evaluation should have priority in its grant process.  
 
The commitment to evidence-based policy has been matched with funding. In June 2000, the 
UK Treasury established the Evidence-Based Policy Fund. With a budget of £4 million over 
two years, the aim of the fund was to support cross-cutting research and links between 
research institutes, universities, and government. Several government departments have 
also contributed funding to the Evidence for Policy and Practice Information and Co-
ordinating Centre (EPPI-Centre)iv. Based at the Institute for Education, University of London, 
the EPPI-Centre collects, reviews and organises the results of evidence-based public policy 
and research in an accessible way for policy-makers and others. The Economic and Social 
Research Council (ESRC) funded the UK Centre for Evidence Based Policy, which was 
based at King’s College London. The centre co-ordinated a network of research centres 
dedicated to promoting evidence-based policy and practice by contributing to the 
development of methods for evaluating and summarising research.  
 
Not only are evidence-based approaches to policy making funded by governments but also 
some government funding is increasingly being tied to demands for evidence. For example, 
proposals to expand the Sure Start programme led to a £16 million research project to 
establish whether the programme was achieving results (see Belsky et al, 2007; Melhuish et 
al, 2008). In the US, the so-called No Child Left Behind Act 2001 enshrines in law the 
principle that federal funds should support educational activities that are based on 
‘scientifically-based research’. Title I funding is designed to help schools improve the 
achievement of disadvantaged students. Those schools that receive Title I funding are 
required by the Act to use effective methods and strategies grounded in scientifically-based 
research.  
 
In addition to executives, legislatures too are beginning to take a strong interest in evidence-
based approaches to policy making. In November 2005, the UK Parliament's Select 
Committee on Science and Technology agreed to establish an inquiry on ‘Scientific Advice, 
Risk and Evidence: How Government Handles Them’. The inquiry examined the extent to 
which polices are evidence-based, what mechanisms are in place for the use of evidence, 
and the way in which guidelines relating to the use of advice are being applied. Issues 
addressed include ‘sources and handling of advice’ and ‘the relationship between scientific 
advice and policy development’. Particular questions explored by the Select Committee 
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include: ‘What mechanisms are in place to ensure that policies are based on available 
evidence?’; ‘Are departments engaging effectively in horizon scanning activities and how are 
these influencing policy?’; and ‘Is Government managing scientific advice on cross-
departmental issues effectively?’ 
 
Although the drive for evidence-based policy is strongest in the UK and US, the movement is 
picking up elsewhere in Europe. In its 2001 white paper on governance, the European Union 
acknowledged that, 
 
‘Scientific and other experts play an increasingly significant role in 
preparing and monitoring decisions. From human and animal health to 
social legislation, the Institutions rely on specialist expertise to anticipate 
and identify the nature of the problems and uncertainties that the Union 
faces, to take decisions and to ensure that risks can be explained clearly 
and simply to the public.’ (Commission of the European Communities, 
2001) 
 
So in the UK, the US, and gradually in Europe, at the executive and legislative levels, and 
pushed by national and international organisations such as the Campbell and Cochrane 
Collaborationsv, institutions and regulations are increasingly attempting to ensure that 
evidence is appropriately considered at various levels of decision-making processes.  
 
Evidence: the missing theory 
Evidence-based policy is on the rise then, and all to the good we should suppose. Except 
that we do not have a theory of evidence that can be called upon in policy deliberations. We 
are supposed to base our policies on evidence but how exactly are we to proceed: what is to 
count as evidence and how shall we use it? My central thesis is that we lack a practicable 
theory of evidence – one that can be put to use for evidence-based policy. There are three 
essential ingredients missing. We do not have: 
• A reasonable and practicable concept of evidence 
• A reasonable and practicable account of what different pieces of evidence say about a 
hypothesis and with what strength they speak (see Hammersley, 2005 for a discussion 
of the variety of kinds of questions evidence can speak to) 
• A reasonable and practicable account of how to evaluate a hypothesis in the light of all 
the candidate evidence. 
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Philosophical accounts of the concept of evidence 
What is it in virtue of which a fact is evidence for a hypothesis? Our philosophical 
accounts fall into two categories. First are accounts based on some features of the 
probabilistic relations between the evidence and the hypothesis – for example, increase in 
probability or various functions of likelihoods (see Mayo, 1996 Chapter 3 for an overview of 
such positions). These are not useful for evidence-based policy. What we need is a concept 
of evidence that we can use to judge whether some fact should be taken into consideration – 
whether it should be ‘on the table’ for consideration. Then we would expect to look at all the 
evidence on the table to decide on the probability of the proposed policy claim. Concepts of 
evidence based on facts about probabilities put the cart before the horse. We need a concept 
that can give guidance about what is relevant to consider in deciding on the probability of the 
hypothesis not one that requires that we already know significant facts about the probability 
of the hypothesis on various pieces of evidence.  
 
Second are those accounts that are based on facts about explanation – for example, 
versions of inference to the best explanation (Lipton, 2004) or explanatory connectedness 
(Achinstein, 2001). The problem here is the concept of explanation. A good many accounts 
end up explaining explanation by reference to probability relations between the ‘explanans’ 
[the means of making plain] and the ‘explanandum’ [that which is being made plain]. This 
simply recreates the previous problem. Also, it seems to me that the concept is too narrow. 
Suppose for example that we are considering a policy to combat segregation, perhaps 
making ‘diversity training’ mandatory in schools. But recall Thomas Schelling’s (1978) game-
theory model where checkers are moved on a checkerboard so as to avoid any one checker 
being the only one of its colour in a group. Eventually clumping occurs even though no 
moves are designed to put checkers in neighbourhoods that are predominately of their own 
colour. This is an important model to consider in judging the efficacy of the program for 
diversity training in reducing segregation. But it is far-fetched to see it as explanatorily 
connected with the claim that the policy will be efficacious.  
 
Besides these problems, our accounts of evidence also tend to be accounts of genuine 
evidence. But we need an account of what makes something candidate evidence. I think I 
can convince you that you have such a concept by pointing out that we are often ready to 
blame people for failing to report facts that, though they may turn out not to be evidence, 
under some scenarios could have been. Mystery stories are rife with examples. In these 
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cases the aim is to evaluate a retrospective rather than a prospective causal claim but the 
point is the same.  
 
Hypothesis: John Jones killed Roger Ackroyd. He could have done so by doing A, B and 
then C. Ah, but he couldn’t because in that case he would have had to travel between Binsey 
and Summertown in 8 minutes and even the fastest car could not do that. But you are 
Jones’s girlfriend and you know he keeps a fast cross-country motorcycle in his garage so he 
could have gotten there across Port Meadow in time. You are blameworthy if you do not 
speak up. Yet if it turns out that A, B and C did not occur, the fact that he owns a dirt bike is 
totally irrelevant to the hypothesis that Jones caused Ackroyd’s death. The case would be 
exactly similar if you were on a commission and did not report some fact you knew that might 
be relevant to the efficacy of a policy under consideration but in the end turns out not to be.  
 
What we are urged to do in practice  
We also have philosophical accounts that provide the second and third components that I 
claim to be missing from our theory of evidence. The problem with these is the same as with 
our philosophical accounts of what evidence is: they are generally not very practicable. They 
are well reasoned and make sense. But they are usually either too abstract or too circular to 
provide useable advice about how to conduct evidence-based policy. By contrast, there are 
now available a host of far more usable schemes – evidence-ranking schemes. The problem 
is that these schemes are not well reasoned and sensible; many seem to me to be daft, 
indeed pernicious. Yet they are being pushed by a number of influential institutions, not the 
least of which are the UK and US governments.  
 
These schemes provide all three of my ‘missing’ components in one fell swoop. Kinds of 
evidence are ranked according to their ‘quality’. Then: (1) Evidence is all and only facts of the 
kind listed in the ranking. (2) All evidence is taken to speak for or against the truth of an 
hypothesis and the strength of its support is in line with its quality: top ranked evidence 
indicates that the hypothesis is very likely true, and as quality decreases, so does the 
strength of support for the truth of the hypothesis. (3) In general the recommendations 
associated with these schemes do not combine evidence at all. Very often the advice is: if 
you have top grade evidence, go with what that says. The US Department of Education, for 
instance, which requires evidence of efficacy in order for a school to receive Title 1 support, 
tells us that RCTs (randomised clinical trials) are needed to establish strong evidence and 
that ‘Two or more typical school settings, including a setting similar to that of your 
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schools/classrooms’ is the quantity of evidence needed.  
 
There are a vast number of similar schemes available. I choose as an example one 
particularly thoughtful one, SIGN (Scottish Intercollegiate Guideline Network)vi. As their own 
document reports:  
 
‘SIGN formerly used the levels of evidence developed by the US Agency for Health 
Care Policy and Research (AHCPR, now the US Agency for Health Research and 
Quality, AHRQ). However as a number of limitations were becoming apparent in that 
system, a review was carried out and new levels of evidence and associated grades 
of recommendation were developed. Following extensive consultation and 
international peer review, the new grading system was introduced in Autumn 2000.’ 
(SIGN, 2008: 36) 
 
The SIGN grading system is this: 
 
SIGN (Scottish Intercollegiate Guideline Network) grading system 
 
Levels of evidence: 
1++  High quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk 
of bias 
1+  Well conducted meta-analyses, systematic reviews of RCTs, or RCTs with a low risk of 
bias 
1 -  Meta-analyses, systematic reviews of RCTs, or RCTs with a high risk of bias 
 
 
2++  High quality systematic reviews of case-control or cohort studies 
High quality case-control or cohort studies with a very low risk of confounding, bias, or 
chance and a high probability that the relationship is causal 
2+  Well conducted case control or cohort studies with a low risk of confounding, bias, or 
chance and a moderate probability that the relationship is causal 
2 -  Case control or cohort studies with a high risk of confounding, bias, or chance and a 
significant risk that the relationship is not causal 
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3  Non-analytic studies, eg. case reports, case series 
 
 
4  Expert opinion 
 
The grading scheme goes like this: 
 
Grades of recommendation: 
A  At least one meta analysis, systematic review, or RCT rated as 1++, and directly 
applicable to the target population; or a systematic review of RCTs or a body of 
evidence consisting principally of studies rated as 1+, directly applicable to the 
target population, and demonstrating overall consistency of results 
B  A body of evidence including studies rated as 2++, directly applicable to the 
target population, and demonstrating overall consistency of results; or 
extrapolated evidence from studies rated as 1++ or 1+ 
C  A body of evidence including studies rated as 2+, directly applicable to the target 
population and demonstrating overall consistency of results; or extrapolated 
evidence from studies rated as 2++ 
D  Evidence level 3 or 4; or extrapolated evidence from studies rated as 2+ 
 
Look now at samples of the kind of advice on offer about how to arrive at an overall 
judgment: 
 
Statements that one piece of ‘level 1++’ evidence is sufficient: 
 
GRADE Working Group: ‘Once the results of high quality randomized trials are 
available, few people would argue for continuing to base recommendations on non-
randomised studies with discrepant results’ (Atkins et al, 2004: 2). [GRADE (Grades 
of Recommendation Assessment, Development and Evaluation) is an international 
project aimed at developing a methodologically sound system that can be applied 
across countries and culturesvii.]   
 
 
SIGN: The following quote from the SIGN 50 document seems to imply that if there 
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are RCTs, the other evidence need not be considered: ‘It is also intended to allow 
more weight to be given to recommendations supported by good quality observational 
studies where RCTs are not available for practical or ethical reasons.’ (SIGN, 2008: 
36) 
 
EBM [Evidence-based medicine]: ‘If the study wasn’t randomized, we’d suggest that 
you stop reading it and go on to the next article in your search’ (Sackett et al, 2000: 
108). 
  
 Cochrane Collaboration: In personal correspondence with Jeremy Howick [co-author], 
Julian Higgins of the Cochrane Collaboration replied to the question of whether 
evidence from RCTs is sufficient, with the following statement: ‘I'm sure there are very 
many people who subscribe to this view [that RCT evidence is sufficient] (if 
interpreted as further evidence on the same questions that the RCTs address). 
Indeed, one might infer this from the fact that the majority of Cochrane reviews 
include only RCTs. This strongly implies that the authors believe there is no need to 
look at other evidence (or believe that 'Cochrane' thinks they shouldn't look at other 
types of evidence). I have much sympathy with this, given the numerous 
unpredictable and largely poorly understood biases in observational studies.’  
  
In answer to the question of whether a single well-done RCT trumps evidence from 
any number of observational studies, Julian Higgins states that ‘If the RCT was done 
well, then I would always claim this is either the right answer or the answer to a 
different question from the observational studies.’  
[The Cochrane Collaboration is dedicated to encouraging RCTs] 
 
So, what’s wrong with that? 
Virtually everything. 
 
1. The concept of evidence involved is too restrictive 
Hardly anything gets on the table. This is bad for a number of different reasons. To start with, 
the type of evidence restricts the type of conclusion for which we can have evidence. These 
schemes are all for judging efficacy claims. But more, concepts in the study have to match 
exactly with those in the policy claim; especially they must be completely operationalisable 
and they must be operationalised in the same way. How could Oxford Council have used 
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evidence like this to decide whether to build a leisure centre in the new housing estate at 
Blackbird Leys? Certainly not in the way envisaged in the grading schemes.  
 
Candidate evidence is not even in the ballpark.  
 
The advantage of an RCT is that it can clinch results. If the ideal conditions for an RCT are 
met, positive results deductively imply that in at least some subpopulations of the 
experimental population the treatment causes the relevant effect. But other methods have 
this advantage as well and they are not in the list. These include various econometric 
modelling techniques, deduction from established theory and experiments in ideal model 
systems (Cartwright, 2007a: Section I.3). 
 
A host of other methods that can vouch for results even if not clinch them are excluded. 
These include the hypothetico-deductive method when used for confirmation, qualitative 
comparative analysis, game-theory modelling, ethnographic methods, and so on. Moreover, 
any ‘voucher’ can be turned into a ‘clincher’ by adding some additional premises - premises 
that may be reasonable to entertain in particular cases. All methods presuppose other 
assumptions. These ranking schemes seem to presuppose that the background assumptions 
required by the methods listed are more likely to be true for all cases than those for methods 
omitted, which is highly implausible.  
 
2. The claims about strength of evidence in the rankings are mistaken 
Much is written about the pros and cons of the specific kinds of evidence that appear in these 
listings – fully randomised trials, partially randomised trials, observational studies, and so 
forth. I want to concentrate instead on the basic underlying ideas, which I think are way off 
base. I have already noted that the kinds of evidence permitted are only good for efficacy 
claims so I shall confine my attention to these, ignoring other policy issues such as claims 
about side effects (which nevertheless turn out to be an important issue in the example I will 
use), about implementation, about the effects of moral, cultural and political considerations, 
about estimates of costs and the like. I shall also concentrate on RCT evidence for 
concreteness but what I say can be carried over, mutatis mutandis, to other types of 
evidence that these rankings admit.  
 
Consider: we wish to evaluate a proposal to do A in order to achieve R: say to treat African 
children who are HIV-infected prophylatically with an inexpensive antibiotic called 
 12 
‘cotrimoxazole’ in order to reduce mortality and morbidity from opportunistic disease until 
they are old enough for retroviral treatment, as in the 2005 UNAIDS and UNICEF call to 
ensure that prophylaxis with cotrimoxazole reaches 80% of children in need by 2010 
(UNAIDS, 2006: 165). An evidence ranking scheme tells us which kinds of evidence speak 
strongly for or against this proposal, which less strongly. In this case the justification for the 
policy is an RCT on children in Zambia published in the Lancet in 2004, which concluded that 
the antibiotic reduced mortality in HIV-infected children by more than 40% (Chintu et al, 
2004: 1870). 
 
What is the underlying logic that shows how a study like this – assuming even that it meets 
all the ideal requirements – can serve as strong evidence for the efficacy of the policy? As far 
as I can see the most plausible construction of the underlying justification assumes that 
actions are justified by principles. We suppose: 
(a) There is a certain type of HIV-infected child population, T, for which the Zambian 
RCT establishes ‘In T cotrimoxazole reduces average morbidity/mortality’. 
(b) The target population – in this case HIV-infected children in resource-poor settings 
across Africa – is of type T. 
(c) So administering cotrimoxazole in the target population will reduce average 
morbidity/mortality. 
 
That is, we need some way to get from the evidence to the conclusion, and a way that shows 
how this evidence can speak so strongly for the conclusion. I think the only way it can work is 
via an intermediate principle. But this won’t do since both the way up to the principle and the 
way back down to the policy are shaky, and for much the same reason: how to specify T. 
This is now explained in more detail. 
 
As regards moving from principle to policy, what is wrong here is what is generally wrong in 
supposing you can read off conclusions about single cases from scientifically established 
principles: almost all principles are defeasible and those that are not (like ‘All men are 
mortal’) do not provide very detailed advice. We can all imagine a vast variety of happenings 
that can defeat the policy efforts even in the face of the principle. One may have the happy 
idea that if the target population is really of the right kind – kind T, whatever that is – the 
defeaters will be distributed the same in the target as in the trial population so the conclusion 
will still obtain. That has its own problems:  
• We do not know what T is. This means that the guidelines may be able to 
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provide sound advice but it is not practicable advice: we do not know how to 
tell whether we are following it or not.  
• Our target population may start out satisfying the characterisation ‘T’, 
whatever that is, but our efforts to implement the policy may change the 
distribution of defeating conditions or the underlying causal structure. This is 
a common worry about interventions in economics (Lucas, 1976, 1988) but 
not much discussed in the evidence-ranking and grading schemes. 
 
In relation to moving from RCT to principle, a positive result in an ideal RCT can establish 
that in at least one subpopulation of the population involved in the trials the treatment causes 
the relevant effect. It can also establish that the average result in this population is 
improvement in the effect. The principle says the treatment causes the relevant effect, or 
produces an average improvement, in any population of type T. How do we get from the first 
to the second? Laying aside Hume’s problem of inductionviii, we suppose that the positive 
result will hold in any population like the one in the trial. Hence the emphasis on identifying T: 
‘like’ in what respects? 
 
This is obviously not an unfamiliar problem. We do of course pay attention to what 
constitutes T. For instance, there were earlier RCTs in Cote d’Ivoire involving the treatment 
of adults with cotrimoxazole (Wiktor et al, 1999) These obviously were not good enough 
because a population of children can be very different from one of adults. Moreover, many 
African children live in areas with high rates of bacterial resistance. So the RCT that is used 
to justify the UNAIDS and UNICEF-proposed policy was performed on children and in 
Zambia where there are high rates of bacterial resistance to cotrimoxazole. But what else 
might be relevant? 
 
The answer is a tough one. The only way to characterize T that works is – ‘populations that 
have just the same causal structure and the same joint probability distribution across all 
relevant variables as the population in the study’. (This is clearly not really true. But this is the 
only characterisation that does not depend on details about what the probability distribution 
or causal structure are - see Cartwright, 2007b for a fuller discussion.) And this is clearly not 
a practicable description. We can try to sidestep the problem by insisting that the 
experimental population be a random sample from the target. How practicable is that, say for 
our cotrimoxazole policy? Moreover, random sampling procedures require a great deal of 
knowledge of the relevant structure of the population sampled if they are to be at all reliable. 
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Not only do we not in general have such knowledge – the guidelines generally do not take 
this much into account. 
 
My basic point here is much the same as the one I made in discussing clinchers and 
vouchers. Nothing can count as evidence for anything except relative to a host of auxiliary 
assumptions; and the strength with which a body of evidence supports a hypothesis can 
never be higher than the credibility of these auxiliaries. The privileged items that tend to 
appear in evidence-ranking schemes have built-in methods for assuring that a few of the 
necessary auxiliaries are met – blinding in RCTs, for example, is good at ensuring that one 
source of confounding for the results is eliminated. But there are huge gaps left. And there is 
no reasonable promise that the gaps are in general smaller than with types of evidence that 
are commonly not even allowed on the table by these schemes.  
 
3. The advice about how to combine evidence is dreadful 
Grading schemes do not combine evidence at all – they go with what is on top. But it seems 
to me to be daft to throw away evidence. Why are we urged to do it? Because we do not 
have a good theory of exactly why and how different types of evidence are evidence and we 
do not have a good account of how to make an assessment on the basis of a total body of 
evidence. Since we lack a prescription for how to do it properly, we are urged not to do it at 
all. That seems daft too. But I think it is the chief reason that operates. That is why the 
philosophical task is so important. 
 
Conclusion 
We need to develop a practicable theory of evidence, a theory that will work for evidence-
based policy. But it had better be a good theory, one that is both sound and usable: that is, a 
theory that is both practicable and philosophical. 
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